Phanes' three technology platforms are designed to build native IgG-like bispecific antibodies that enhance drug-like properties.
PACbody®: Build native IgG-like bispecific antibodies.
SPECpair®: Build bispecific antibodies with enhanced manufacturability.
ATACCbody®: Build bispecific antibodies with modulated activities.
